Patents by Inventor Gerd Koehler

Gerd Koehler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8303533
    Abstract: A device for delivery of glucose-regulating medication, particularly insulin, depending on the measured tissue glucose concentration, having a sensor for measuring the glucose concentration in tissue fluid, possibly a unit for removing fluid from subcutaneous tissue, as well as a container for the glucose-regulating medications, having a unit for subcutaneous delivery of the glucose-regulating medications, and having a unit connected to the glucose sensor for regulating the quantity of the glucose-regulating medication to be delivered depending on the measured tissue glucose concentrations. The device simulates the function of the natural pancreas and is constructed small and compact.
    Type: Grant
    Filed: March 29, 2006
    Date of Patent: November 6, 2012
    Assignee: Medizinische Universitaet Graz
    Inventors: Werner Regittnig, Thomas Pieber, Lukas Schaupp, Martin Ellmerer, Gerd Koehler
  • Publication number: 20090005724
    Abstract: A device (10) for delivery of glucose-regulating medication depending on the measured tissue glucose concentration, having a sensor (7) for measuring the glucose concentration in the tissue fluid, possibly a unit (1) for removing fluid from subcutaneous tissue (11), as well as a container (14) for the medications, having a unit (23) for subcutaneous delivery of the glucose-regulating medications, and having a unit (12) connected to the glucose sensor (7) for regulating the delivery of the glucose-regulating medication depending on the measured tissue glucose concentrations. To provide a device (10) simulating the function of the natural pancreas and being compact, the sensor (7) for measuring the tissue glucose concentration or the unit (1) for removing the tissue fluid is combined with the delivery unit (23), particularly in a shared catheter (25), so that the measurement of the tissue glucose concentration is essentially performed at the location of the delivery of the glucose-regulating medication.
    Type: Application
    Filed: March 29, 2006
    Publication date: January 1, 2009
    Applicant: Medizinishe Universitat Graz
    Inventors: Werner Regittnig, Thomas Pieber, Lukas Schaupp, Martin Ellmerer, Gerd Koehler